Abiopharma

🔍 Parker Matthew A. (Executive)

Company: FIRST US BANCSHARES, INC. (FUSB)

Report Date: 2026-06-26

Detailed Transactions and Holdings:

• Acquired 300 shares of Common Stock, $.01 par value at $11.71 per share (Direct)
  Date: 2026-06-26 | Code: M | equity_swap_involved: false | shares_owned_after: 3,213.00 | transaction_form_type: 4
• Sold 241 shares of Common Stock, $.01 par value at $16.75 per share (Direct)
  Date: 2026-06-26 | Code: F | equity_swap_involved: false | shares_owned_after: 2,972.00 | transaction_form_type: 4
• Acquired 300 shares of Common Stock, $.01 par value at $10.01 per share (Direct)
  Date: 2026-06-26 | Code: M | equity_swap_involved: false | shares_owned_after: 3,272.00 | transaction_form_type: 4
• Sold 221 shares of Common Stock, $.01 par value at $16.75 per share (Direct)
  Date: 2026-06-26 | Code: F | equity_swap_involved: false | shares_owned_after: 3,051.00 | transaction_form_type: 4
• Sold 300 shares of Stock Option (right to buy) at $11.71 per share (Derivative)
  Date: 2026-06-26 | Code: M | Expires: 2028-02-12 | Exercise: 2019-02-12 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1
• Sold 300 shares of Stock Option (right to buy) at $10.01 per share (Derivative)
  Date: 2026-06-26 | Code: M | Expires: 2029-02-27 | Exercise: 2020-02-27 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: These options were granted on February 12, 2018, and vested in equal installments on each of the first three anniversaries of the date of grant.
• F2: These options were granted on February 27, 2019, and vested in equal installments on each of the first three anniversaries of the date of grant.